The Advanced Wound Care Summit is wound care’s only industry-led forum
It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies.
Whether an established wound care company, an emerging startup, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.
To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more.
HEAR FROM OUR AUDIENCE
WHO ATTENDS

INNOVATION SHOWCASE
If you are an innovative wound care start-up, the Innovation Showcase is a unique opportunity to present your products to our renowned selection committee and the entire live audience – consisting of investors, strategic M&A scouts, CXOs, VPs and Directors of R&D.
Nine companies, hand-picked by our committee, will take to the stand to deliver quick fire presentations about their product or service and how they are aiming to revolutionize wound care.
All applications are stage agnostic and can relate to any solutions within advanced wound care, from anti-biofilm dressings to remote monitoring devices. Apply here to ensure you elevate your brand in a room of potential investors and world leaders of wound care research. Deadline for submissions is June 9th.
The Winner of the showcase will be published in Wound Central and automatically shortlisted into the JWC Awards.
Wound Central brings together the publishing expertise of Journal of Wound Care and over 50,000 health professionals trained by or associated with the WCEI, AAWC AVLS, APWH, and ACCWS, providing a new double-blind peer reviewed journal. Wound Central is targeted at physicians, nurses, scientists, researchers, and academics by bringing together research, reviews and expert opinion pieces all in one place
*All applicants must be interested in attending the event and must purchase a ticket to be a part of the showcase if successful.
INNOVATION SHOWCASE SELECTION COMMITTEE

Kris Kieswetter

Thomas Busby
Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.
Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.
Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

Ibraheem Badejo
Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.
From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.
During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.
Ib received his BA degree in chemistry from Avila University. He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Parth Desai

Artem Trotsyuk
CEO & Founders Forum
The perfect environment for you to establish a credible, peer-to-peer network of wound care entrepreneurs. As the name suggests, this is an exclusive meeting space available to CEOs and Founders only. Join this forum to form relationships with other with like-minded peers and explore the plethora of partnership opportunities available to wound care decision makers.
This forum is limited to only 25 spaces. When securing your place for the event, make sure to register your interest in the forum to avoid missing out on opportunity to network face-to-face with leaders of this thriving community.
WHO YOU WILL MEET
2023 SPEAKERS

Kris Kieswetter

Ibraheem Badejo
Ibraheem (Ib) is Senior R&D Director, External Front End Innovation at Johnson & Johnson Innovation, Boston. He leverages his expertise in smart materials and biomaterials to support the medical device sector.
From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by J&J in 2005). Prior to joining Closure, he held various positions at Bayer, North Carolina State University, College of Charleston. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.
During his career, Ib has led teams in the development of commercialized biomaterials based products and new technology / products licensed or acquired.
Ib received his BA degree in chemistry from Avila University. He received his PhD in Organic chemistry from the University of Toledo, where he was the Robert Whiteford Memorial Scholar for Outstanding Graduate Research and a Petroleum Research Fund Fellow. He is also the recipient of 24 US patents with others pending

Jon Bloom

Jignesh Patel

Julie Morabito
Assistant Director, Division of Infection Control and Plastic and Reconstructive Surgery at FDA’s Center for Devices and Radiological Health (CDRH). (Plastic Surgery Skin and Wound Devices Team).

Monique Rennie

Ira Herman

Katherine Piette

Mike Griffiths

Mitch Sanders

Davide Vigano
Sensoria designs, develops and produces bio-sensing wearable garments. The vision of the company is that the Garment itself will become the next ultra-personal, mobile computer. Davide is a former Microsoft partner level executive with over 25 years of sales, marketing and extensive product management experience. As an intern he started the international localization group for MacWorks and MacOffice in 1987. More recently, he served as General Manager of the Health Solutions Group where he was in charge of marketing and product strategy for both HealthVault and the Amalga product line. He acted as Vice President of the Worldwide SMSP Medium Business division which he grew 18% YOY to over $14B. Davide also managed the Italian Marketing, Business and Enterprise operations for five years and brought it to number one in the world for contribution margin, 6th largest Microsoft subsidiary in the world by revenues.

Parth Desai

Chris Rao

Thomas Serena
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.
To date he has opened and operates wound care centers across the United Sates and globally. Dr. Serena has been the lead or Principal investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He founded the first wound healing cooperative research group that produced more than 12 manuscripts in 2016 alone. In 2011 he developed a diagnostic technique that now bears his name (The Serena Technique©). He holds numerous patents on wound care devices and dressings.
He is recognized internationally as an expert in the field of wound healing: He has more than 200 published papers and has given more than 1000 invited lectures throughout the world. He has published three medical textbooks and authored numerous book chapters. He has been a member of the Board of Directors of the Wound Healing Society and served two terms on the board of the Association for the Advancement of Wound Care (AAWC) and is now the President-Elect. He has also been Vice-President of the American College of Hyperbaric Medicine and President of the American Professional Wound Care Association.
Dr. Serena has done extensive medical relief work with Health Volunteers Overseas and served as chairman of the AAWC Global Volunteers/HVO Steering Committee until 2016. In 2016 in partnership with HEAL Foundation he opened a wound clinic in Ho Chi Minh, Vietnam. Outside of wound healing, he consulted for the government of Rwanda on AIDS prevention research.

Nikolai Sopko
Dr. Nikolai Sopko obtained his MD with honors from Case Western Reserve University and PhD in stem cell biology at the Cleveland Clinic as a graduate of the National Institutes of Health Medical Scientist Training Program. He completed his surgical training at the Johns Hopkins James Buchanan Brady Urologic Institute as a Physician Scientist Scholar where he focused on regenerative reconstruction, tissue engineering, gene therapy, transplant modulation and tumor biology. He has over 60 published peer-reviewed articles and book chapters and is a speaker on regenerative medicine. Dr. Sopko is currently the Chief Scientific Officer and Vice President of Research and Development of PolarityTE where he applies his passion for patient care and basic science

Kenny Carberry
Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers a wide array of indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle from generating a comprehensive strategy through executing a successful trial.

David Alper

Jens Kirsch

Windy Cole

David Navazio

Anthony Kerr

Tim Ganey

Dan King

Melissa Bailey

Alan Sage
CONFERENCE PACKAGE
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Ticket price will increase after
— June 15, 2023 —
ACCESS YOUR COPY OF THE BROCHURE
The 2023 agenda is here!
Fill out the short form to access a copy immediately.
WHAT’S NEW THIS YEAR?
- Interactive Roundtables
Foster new connections across roundtable discussions centered on the key challenges affecting wound care executives today - Expanded Innovation Showcase
With opportunities for emerging start-ups and mid-size brands, apply to pitch your innovation to our room of investors and strategic partners - More Key Players
Meet the game changers from across the industry including 3M, Smith & Nephew, Convatec, Molnlycke and Coloplast, with all stakeholders under one roof - Improved Networking Opportunities
Meet your next collaborator, with a revamped programme allowing for more business partnering opportunities than ever with over 8 hours of dedicated networking time
FILL OUT YOUR DETAILS BELOW:
DIAMOND PARTNER
Advanced Oxygen Therapy Inc
Website: https://aotinc.net/
At AOTI, we are helping all people with chronic conditions get back to living their lives to the fullest. We do this by enhancing access to care, improving clinical outcomes and quality of life, and advancing health equity.
GOLD PARTNER
Natrox
Website: https://www.natroxwoundcare.com/
Delivering wound care technology that works seamlessly across the care continuum and that can transform patients' lives.
We deliver advanced solutions to aid wound healing—even in chronic, non-healing wounds.
SILVER PARTNER
Ascend Materials
Website: https://www.ascendmaterials.com/
Ascend Performance Materials makes high-performance materials for everyday essentials and new technologies.
Our focus is on improving quality of life and inspiring a better tomorrow through innovation. Based in Houston, Texas, and with regional offices in Shanghai, Brussels and Detroit, we are a fully integrated material solutions provider with global manufacturing facilities in North America, Europe and Asia. Our global workforce makes the materials used to make safer vehicles, cleaner energy, better medical devices, smarter appliances and longer-lasting apparel and consumer goods. We are committed to safety, sustainability and the success of our customers and our communities.
Vaporox
Website: https://vaporox.com/
Having received FDA 510(k) clearance for its patented VHT-200 wound healing medical device on March 23. 2023, Vaporox is marketing its Vaporous Hyperoxia Therapy (VHTÔ), a breakthrough technology for healing diabetic foot ulcers (DFUs) to medical doctors and podiatrist in private practice.
Both clinical studies and commercial results show that Vaporox’s VHT-200 heals 85% of the DFUs that resist “the standard of care,” making it by far the best DFU treatment available. VHT gets comparable results in real world use as well.
The VHT-200 brings advanced wound care to private providers’ offices. It also greatly improves practice economics. With VHT treatments reimbursed by a Category 1 CPT code, adoption of VHT will typically improve a provider’s DFU healing efficacy by 2x to 3x while increasing their per-patient revenues by 5x to 6x, while allowing them to provide Advanced Wound Care, in their practice.
Delivering a VHT treatment requires only about 10 minutes of a med tech’s time. The device is nearly maintenance free, and the continuously reports its status via IoT, allowing proactive field support.
Vaporox’s “pay-per-treatment” sales model enables provider adoption with no up-front cost or risk. This produces recurring revenue for the company while shortening sales cycles and minimizing sales and marketing costs.
VHT treatment of all newly-occurring U.S. DFUs would require about 22,000 VHT-200s and yield Vaporox revenues of about $1.6 billion/year, with very high margins.
NETWORKING PARTNER
EXHIBITOR
Intellicure
Website: https://www.intellicure.com/
Intellicure Analytics is a unique, easy-to-use, advanced wound care data platform and the go-to resource for researchers and marketers across the life sciences industry.
The secret behind our finely structured data is in how wound care practitioners chart their patient encounters using IntellicureEHR’s standardized data collection method and incorporation of clinical quality metrics.
Intellicure’s wound care EHR software was built to leverage structured wound data that can be used to change the way health care is delivered and improve patient outcomes. When wound care providers document a patient encounter inside Intellicure’s wound care apps, they select clinically relevant options from drop-down lists that are supported by evidence-based decision support engines, rather than typing free-text or dictating notes.
Because IntellicureEHR incorporates CMS-recognized quality measures and peer-reviewed algorithms specific to wound care, there is a very high degree of accuracy associated with critical information like comorbid conditions, diagnosis codes, procedures, treatments, and outcomes. This avoids the inconsistencies often created by differing use of terminology and unstructured notes. Discrete data fields are populated with discrete information, eliminating the need for curation downstream and making it possible to quickly turn real-world data into real-world evidence.
MEDIA PARTNERS
Journal of Wound Care
Website: https://www.journalofwoundcare.com/
Please visit our website for more information.Pharma Journalist
Website: https://www.pharmajournalist.com/
Please visit our website for more information.Select Science
Website: https://www.selectscience.net/
Please visit our website for more information.Technology Networks
Website: https://www.technologynetworks.com/
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.
International Wound Journal
Website: https://onlinelibrary.wiley.com/journal/1742481x
Please visit our website for more information.Wound Care Professional
Website: https://www.woundcare-professional.com/
Please visit our website for more information.Wound Care Weekly
Website: WoundCareWeekly.com
WoundCareWeekly.com is the world’s most comprehensive source of all things wound care, including events, news, white papers, studies and much more. We review close to 50 sources worldwide and post daily to the website and send the latest developments to our database of wound care pros and podiatrists weekly.
Wound Central
Website: https://www.jwc-woundcentral.com/
Please visit our website for more information.Partner with us
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected]
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Venue
Aloft Boston Seaport District, 401-403 D Street, Boston, MA, 02210
We're excited to welcome you in Boston at The Aloft Boston Seaport District for the Advanced Wound Care Summit!
To book your room at a discounted rate, please use the link here. This will expire June 23rd.
You can also use Hotel Map: https://hotelmap.com/MYTPK
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.